
Home » MERCK IN CANCER RESEARCH DEAL WITH AVEO
MERCK IN CANCER RESEARCH DEAL WITH AVEO
November 2, 2005
Pharmaceutical firm Merck & Co. is joining with privately-held Aveo Pharmaceuticals
Inc. to develop certain targeted cancer therapies, Aveo said Wednesday. The
company did not provide financial details in a news release. The agreement,
Merck's second with Aveo, covers the use of Aveo technology to identify patient
groups likely to respond to a number of experimental cancer drugs Merck is currently
developing.
Forbes
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
10Mar
-
16Mar
-
18Mar
-
23Mar
-
30Mar
-
06Apr